# Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia

> **NCT02533219** · — · NO_LONGER_AVAILABLE · sponsor: **Baylor College of Medicine**

## Conditions studied

- Hyperinsulinemic Hypoglycemia, Persistent
- Congenital Hyperinsulinism
- Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)

## Interventions

- **DRUG:** 18 F-DOPA

## Key facts

- **NCT ID:** NCT02533219
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02533219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02533219, "Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02533219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*